CRUCIANI FABOZZI, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 125
EU - Europa 100
AS - Asia 69
SA - Sud America 6
AF - Africa 1
Totale 301
Nazione #
US - Stati Uniti d'America 120
IT - Italia 32
CN - Cina 28
IE - Irlanda 20
SG - Singapore 19
SE - Svezia 17
DE - Germania 15
HK - Hong Kong 8
TR - Turchia 7
FI - Finlandia 5
IN - India 5
BR - Brasile 4
CA - Canada 4
FR - Francia 3
GB - Regno Unito 3
NL - Olanda 3
AM - Armenia 1
KE - Kenya 1
LK - Sri Lanka 1
MX - Messico 1
PY - Paraguay 1
RU - Federazione Russa 1
UA - Ucraina 1
VE - Venezuela 1
Totale 301
Città #
Chandler 24
Dublin 20
Singapore 17
Ann Arbor 14
Ashburn 12
Santa Clara 12
Munich 11
Hong Kong 8
Dearborn 7
Izmir 7
Parma 7
Beijing 6
New York 5
Turku 5
Nanchang 4
Shanghai 4
Wilmington 4
Boardman 3
Bremen 3
Hebei 3
Livorno 3
Milan 3
Princeton 3
Pune 3
Redwood City 3
Toronto 3
Los Angeles 2
Nanjing 2
Rockville 2
Segrate 2
Asunción 1
Atlanta 1
Belém 1
Chennai 1
Colombo 1
Des Moines 1
Fairfield 1
Falls Church 1
Frankfurt am Main 1
Guangzhou 1
Haikou 1
Hefei 1
Jinan 1
Kunming 1
La Guaira 1
Leawood 1
Leme 1
Mexico City 1
Nairobi 1
Ningbo 1
Nova Friburgo 1
Philadelphia 1
Rio Saliceto 1
Rome 1
Salvador 1
San Mateo 1
Turin 1
Wigan 1
Woodbridge 1
Yerevan 1
Zhengzhou 1
Totale 233
Nome #
Latent tuberculosis infection in patients with chronic plaque psoriasis: Evidence from the Italian Psocare Registry 121
Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: Results from the Italian Psocare Registry 100
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients 89
Totale 310
Categoria #
all - tutte 1.400
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.400


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202127 0 2 4 1 3 2 1 3 6 2 3 0
2021/202218 0 0 4 1 0 0 0 1 2 2 1 7
2022/202370 7 9 4 10 5 9 1 2 21 1 1 0
2023/202425 1 1 0 1 4 8 1 0 2 2 1 4
2024/202591 2 6 6 4 12 9 0 3 12 12 10 15
2025/202614 14 0 0 0 0 0 0 0 0 0 0 0
Totale 310